Search
for
Sort by
Research 30 of 54
- Rapid hair depigmentation in patient treated with pazopanib
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- S1‐Guideline Cutaneous Angiosarcomas – Update 2021
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- Reporting on Adverse Clinical Events
- The PDGF/PDGFR pathway as a drug target
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Anagen effluvium
- Hair disorders in patients with cancer
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Cancer Treatments and Alopecia: A Systematic Review
- Dermatologic Adverse Events from Cancer Treatments
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Chemotherapy and Cutaneous Drug Reactions
- Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Chemically Induced Hair Loss/Alopecia
- Hair Changes due to Drugs
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Index
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Hair Graying Regulators Beyond Hair Follicle
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies